Financhill
Back

Oncternal Therapeutics Quote, Financials, Valuation and Earnings

Oncternal Therapeutics Price Quote

$1.19
-0.10 (-7.75%)
(Updated: November 12, 2024 at 5:55 PM ET)

Oncternal Therapeutics Key Stats

Sell
35
Oncternal Therapeutics (ONCT) is a Sell

Day range:
$1.23 - $1.33
52-week range:
$1.05 - $13.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.24%

Volume:
82K
Avg. volume:
123.6K
1-year change:
-77.76%
Market cap:
$3.8M
Revenue:
$0
EPS:
$-12.15

How Much Does Oncternal Therapeutics Make?

Data Unavailable

Is Oncternal Therapeutics Growing As A Company?

Data Unavailable

Oncternal Therapeutics Stock Price Performance

What Is Oncternal Therapeutics 52-Week High & Low?

Oncternal Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Oncternal Therapeutics?

Is Oncternal Therapeutics Cash Flow Positive?

  • What Is ONCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$25.2M
  • What Is Oncternal Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$137K
  • What Is Oncternal Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $15.9M

Oncternal Therapeutics Return On Invested Capital

Data Unavailable

Oncternal Therapeutics Earnings Date & Stock Price

Oncternal Therapeutics Competitors

Oncternal Therapeutics Dividend Yield

Oncternal Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 10.49%
Revenue: 0% 259.27%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 2.00
Upside from Last Price: 55.04%

Major Shareholders

  • How many ONCT shares are owned by institutional investors?
    760.2K ONCT shares are owned by institutional investors
  • How many ONCT shares are owned by insiders?
    0 ONCT shares are owned by insiders